Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|February 2, 2008
1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinityGavin A Whitlock, Julian Blagg, Paul V FishBioorganic & Medicinal Chemistry Letters|April 28, 2009
Potent and selective alpha1A adrenoceptor partial agonists--novel imidazole frameworksGavin A Whitlock, Paul E Brennan, Lee R Roberts, et al.Bioorganic & Medicinal Chemistry Letters|May 6, 2009
6,7-Dihydro-5H-pyrrolo[1,2-a] imidazoles as potent and selective alpha1A adrenoceptor partial agonistsLee R Roberts, Paul V Fish, R Ian Storer, et al.Bioorganic & Medicinal Chemistry Letters|November 22, 2007
A novel series of highly selective inhibitors of MMP-3Gavin A Whitlock, Kevin N Dack, Roger P Dickinson, et al.Bioorganic & Medicinal Chemistry Letters|February 3, 2007
N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitorsPaul V Fish, M Jonathan Fray, Alan Stobie, et al.Bioorganic & Medicinal Chemistry Letters|December 5, 2008
Chloroquine-astemizole hybrids with potent in vitro and in vivo antiplasmodial activityChitalu C Musonda, Gavin A Whitlock, Michael J Witty, et al.Bioorganic & Medicinal Chemistry Letters|April 18, 2008
Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuityGavin A Whitlock, Paul V Fish, M Jonathan Fray, et al.Bioorganic & Medicinal Chemistry Letters|December 19, 2008
Synthesis and evaluation of 2-pyridyl pyrimidines with in vitro antiplasmodial and antileishmanial activityChitalu C Musonda, Gavin A Whitlock, Michael J Witty, et al.Bioorganic & Medicinal Chemistry Letters|August 4, 2009
Discovery of a novel azepine series of potent and selective 5-HT2C agonists as potential treatments for urinary incontinencePaul E Brennan, Gavin A Whitlock, Danny K H Ho, et al.Bioorganic & Medicinal Chemistry Letters|November 5, 2008
Novel 2-imidazoles as potent, selective and CNS penetrant alpha1A adrenoceptor partial agonistsLee R Roberts, Justin Bryans, Kelly Conlon, et al.Pageof 3